Original Research

Health and participation in the Lolland-Falster Health Study: a cohort study

Abstract

Background Lolland-Falster is the area of Denmark with highest mortality. However, clinical measurements from a population-based health survey showed prevalence of disease indicators similar to those in the rest of Denmark. The study aimed to disentangle this paradox.

Methods The Lolland-Falster Health Study (LOFUS) took place in 2016–2020. We followed the 53 000 invited persons up for mortality from invitation date to 1 February 2023. Log-binomial regression was used to calculate relative risk (RR) of non-participation versus participation in LOFUS by subgroups of sex, age, municipality, residency group, household composition and economic status. Using Poisson regression, mortality rate ratio (MRR) was calculated between subgroups and within subgroups for non-participants versus participants for all-cause mortality and mortality from cancer, cardiovascular diseases, respiratory diseases, external causes and other diseases.

Results One-third (36%) of persons invited to LOFUS participated. Only modest differences were seen in participation across subgroups; the largest being an RR of 1.37 (95% CI 1.35 to 1.40) for publicly supported versus self-supported persons. However, non-participants had higher mortality than participants (MRR 3.08, 95% CI 2.82 to 3.37). This pattern was consistent across all subgroups and was found for both all-cause and cause-specific mortality.

Conclusion The paradox we observed could partly be attributed to participation differences between subgroups. However, for the lack of population representativeness of the survey data, our study indicated within-group selection, measured by excess mortality of non-participants, to be much more important than between-group selection. One should therefore be cautious in using even weighted health survey data for prioritising health interventions.

What is already known on this topic

  • In population-based health surveys, weighting of responses by sociodemographic variables is often used to estimate the population representative response pattern.

  • Weighted data are used often as basis for prioritising health interventions.

What this study adds

  • Lolland-Falster Health Study (LOFUS) was a Danish health survey with a participation rate of 36%.

  • In LOFUS, we found only modest differences in non-participation across sociodemographic variables, indicating limited selection between subgroups.

  • However, in the years following invitation to LOFUS, non-participants had, within each subgroup, about three times the mortality of participants, indicating considerable selection within subgroups.

How this study might affect research, practice or policy

  • Due to selection within subgroups, one should be cautious in using even weighted health survey data for prioritising health interventions.

Introduction

With slightly less than 6 million inhabitants, Denmark is in many ways a small and homogeneous country. Nevertheless, while the life expectancy of the rural-provincial islands of Lolland-Falster is 78.8 years, it is 83.7 years in the coastal suburbs north of the capital of Copenhagen, and 81.3 years nationwide.1 The difference between the lowest and highest level of almost 5 years equals the growth in national life expectancy over 20 years.2

In this century, a number of population-based health surveys have been undertaken in Denmark mostly focused on populations living in or close to Copenhagen, such as the Copenhagen General Population Study,3 the Health 2006 Study,4 and the Copenhagen Aging and Midlife Biobank.5 The Diet, Cancer and Health–Next Generation covered Copenhagen and the second largest city, Aarhus.6 The Danish Health Examination Survey was a national initiative,7 the Danish General Suburban Population Study covered the provincial town of Næstved8 and the Lolland-Falster Health Study (LOFUS) the Lolland-Falster islands.9 All surveys included self-administered questionnaires, clinical examinations and collection of biological samples.

Given the relatively low life expectancy in Lolland-Falster, one would expect this pattern to be reflected in the LOFUS health data. However, analysis of glycated haemoglobin in the blood samples from LOFUS participants aged 18 years and above showed a prevalence of pre-diabetes of 5.8%,10 which was between the levels of 4.3% and 6.9% found in other Danish health surveys.11 The prevalence of undiagnosed diabetes was 0.8%, between the levels of 0.7% and 1.4% in the other surveys.11 Furthermore, analysis of the ratio between the forced expiratory volume in 1 s and the forced vital capacity in LOFUS participants aged 35 years and above showed a prevalence of airway obstruction of 19%,12 which was in line with levels of 17.4%13 and 18%,14 respectively, found in similarly measured data from other Danish surveys.

These paradoxical observations could indicate considerable health selection among LOFUS participants either between sociodemographic groups or within each of these groups. On this basis, we examined sociodemographic selection in participation among persons invited to LOFUS, and by follow-up of the entire cohort of persons invited to LOFUS, mortality differences between participants and non-participants.

Material and methods

Individual-level LOFUS data combined with data from the Danish Civil Registration System (CRS), the Socio-Economic Classification (SOCIO13) and the Danish Register of Causes of Death were linked using the CRS numbers.

Lolland-Falster Health Study

Invitations to LOFUS were sent to people aged ≥18 years living in Lolland-Falster and selected randomly from CRS.8 Selected persons were invited together with all household members. Data were collected between 2016 and 2020 with self-administered questionnaires; clinical examinations, as well as collection of biological samples for same-day analysis and biobanking, were performed by trained personnel. In total, 53 313 persons were invited to LOFUS and 18 949 participated (35.5% response rate). From the invited persons, we excluded 25 persons who died and 144 persons who emigrated prior to invitation according to the updated CRS data, leaving a study population of 53 144.

Baseline characteristics

We used CRS data to categorise persons invited to LOFUS by sex, age, municipality, residency group and household composition by date of invitation to LOFUS. Age at date of invitation was categorised into 0–29, 30–64 and ≥65 years, and municipality into Lolland and Guldborgsund. Household composition was divided into single or multiple adults (≥18 years). Residency group was based on the CRS address history during the 10 years prior to invitation date. Long-term residents lived in Lolland-Falster during all 10 years; in-migrants had moved to Lolland-Falster from other parts of Denmark during these 10 years; and persons from other countries had immigrated to Lolland-Falster. SOCIO13 holds information on income source during the main part of each year. We categorised persons of ‘working age’ (age 30–64 years) by income source the year before invitation to LOFUS. Persons aged <30 or ≥65 years at invitation date were not categorised by income source.

Follow-up

All persons were followed up in CRS from the LOFUS invitation date until death, emigration or 1 February 2023, whichever came first. Causes of death were available up to 31 December 2021 and categorised into five mutually exclusive categories: cancer, cardiovascular diseases, respiratory diseases, external diseases and other diseases (see online supplemental table 1).

Statistical analysis

The relative risk (RR) of non-participation in LOFUS by sex, age, municipality, residency group, household composition and economic status (only persons aged 30–64 years) was analysed using a log-binomial model.15 We calculated crude RR, and sex and 5-year age group at date of invitation adjusted RR. The mortality risk ratios (MRRs) between subgroups of invited persons and between non-participants and participants were analysed by sex, age, municipality, residency group, household composition and economic status (only persons aged 30–64 years) using Poisson regression.16 We calculated crude MRR; and sex, 5-year age group during follow-up, and calendar year adjusted MRR. Analysis was performed in SAS 9.4 and graphics were made in R 4.2.2.

Patient and public involvement

The present study was entirely based on already available register data, and neither patients nor the public were involved in the undertaking of the study. Subjects contributing data to the original LOFUS provided informed consent for use of the data in future research.

Results

Participation

The study included 18 949 LOFUS participants and 34 195 non-participants (table 1). The mean age was 49.4 years (0–96 years) for participants and 44.7 years (0–106 years) for non-participants.

Table 1
|
Number of persons invited to the Lolland-Falster Health Study, percentage of participants and relative risk (RR) of non-participation versus participation with 95% CI by sociodemographic variables

The crude RR of non-participation in LOFUS was higher for men than for women (RR 1.08; 95% CI 1.06 to 1.09), and adjustment for sex and age did not change this pattern (RR 1.07; 95% CI 1.06 to 1.08). Non-participation was highest for the age group 0–29 years (RR 1.21; 95% CI 1.19 to 1.23) as compared with the oldest age group (≥65 years), which had the same non-participation rate as those aged 30–64 years. There was no difference in non-participation between the municipalities of Guldborgsund and Lolland. In-migrants had higher non-participation than long-term residents in Lolland-Falster (RR 1.08; 95% CI 1.07 to 1.10), and so had persons who recently moved to Lolland-Falster from abroad (RR 1.11; 95% CI 1.10 to 1.13). Persons in single-adult households had higher non-participation than persons in multiple-adult households (RR 1.12; 95% CI 1.11 to 1.13). In the age group 30–64 years, persons on public support had higher non-participation than self-supported persons (RR 1.37; 95% CI 1.35 to 1.40).

Mortality between subpopulations

During the average follow-up of 4.68 years for all-cause mortality, persons invited to LOFUS in total accumulated 248 812 person-years and 3514 deaths (table 2 and online supplemental table 2). There was some tendency for subgroups with high non-participation to have higher mortality than subgroups with low non-participation. For instance, men had higher mortality than women (crude MRR 1.17; 95% CI 1.10 to 1.25 and adjusted MRR 1.41; 95% CI 1.32 to 1.50). Persons living in single-adult households had higher mortality than persons in multiple-adult households (MRR 1.75; 95% CI 1.63 to 1.88). In the age group 30–64 years, persons on public support had higher mortality than self-supported persons (MRR 4.54; 95% CI 3.85 to 5.36), and living in a single-adult household resulted in an MRR of 2.68 (95% CI 2.29 to 3.15) (online supplemental table 3). However, invited persons aged ≥65 years had low non-participation, and as expected, they had much higher mortality than the younger age groups. Given that the oldest age group contributed almost one-fourth (59 551 of 248 812) of the person-years in the cohort, it is clear that LOFUS participation was not dominated by healthy subgroups. In this age group, living in a single-adult household resulted in an MRR of 1.57 (95% CI 1.44 to 1.70) (online supplemental table 4).

Table 2
|
Number of person-years (PY) and deaths for persons invited to the Lolland-Falster Health Study, and mortality rate ratio (MRR) with 95% CI between sociodemographic groups (follow-up from invitation date to 1 February 2023)

Mortality within subpopulations

Non-participants in LOFUS had an excess all-cause mortality compared with participants (crude MRR 2.94; 95% CI 2.69 to 3.22 and adjusted MRR 3.08; 95% CI 2.82 to 3.37) (table 3). Restricted to the age group 30–64 years, the adjusted MRR was 3.53 (95% CI 2.89 to 4.32). The excess mortality of non-participants was found across sex, age, municipality, residency, household composition and economic status, and it varied among all groups at around threefold risk being 3.66 (95% CI 3.09 to 4.32) for single adults and 2.76 (95% CI 1.59 to 4.80) for in-migrants. Outliers due to small numbers were estimated for persons aged 0–29 years and for persons who had recently moved to Lolland-Falster from other countries. The pattern for persons aged 30–64 years at invitation followed closely that for all ages with an adjusted MRR for the total group of 3.53 (95% CI 2.89 to 4.32), split between 2.19 (95% CI 1.64 to 2.92) for self-supported persons and 3.31 (95% CI 2.45 to 4.47) for publicly supported persons.

Table 3
|
Number of person-years (PY) and deaths for participants and non-participants invited to the Lolland-Falster Health Study, and mortality rate ratio (MRR) with 95% CI for non-participants compared with participants within sociodemographic groups (follow-up from invitation date to 1 February 2023)

During the average follow-up of 3.67 years for cause-specific mortality, persons invited to LOFUS in total accumulated 194 971 person-years and 2633 deaths (table 4). The adjusted MRR for non-participants compared with participants was 3.68 (95% CI 3.29 to 4.11). Restricted to the age group 30–64 years, it was 4.14 (95% CI 3.14 to 5.44). The excess mortality for non-participants compared with participants was thus slightly higher during the first 3.67 years of follow-up compared with the full 4.68 years of follow-up. The excess mortality was seen across all major causes of death with the lowest estimate for cardiovascular diseases in the age group 30–64 years (MRR 2.75; 95% CI 1.42 to 5.35) and the highest estimate for respiratory diseases in the same age group (MRR 7.41; 95% CI 2.25 to 24.37).

Table 4
|
Person years (PY), deaths and mortality rate ratio (MRR) with 95% CI for non-participants compared with participants in the Lolland-Falster Health Study (follow-up to 31 December 2021)

Discussion

Main results

Only one-third of the 53 000 persons invited to LOFUS participated. Nevertheless, there were very modest differences in participation rates across subgroups, when invited persons were classified by six sociodemographic variables available for all invited persons (figure 1). Furthermore, participating subgroups were not particularly healthy, as participation was, for instance, high in elderly persons. Our study thus showed that between-group selection did not seriously affect the LOFUS data. However, among the 53 000 invited persons, in total, 3516 persons died during the average follow-up period of 4.68 years, and the death rate was three times higher for the two-thirds of non-participants compared with the one-third of participants. This pattern of excess mortality in non-participants was found across all subgroups classified by the six sociodemographic variables. Our study therefore showed a considerable health selection in participation within groups. Therefore, healthy persons participated in LOFUS to more or less the same extent independently of their sociodemographic background, but unhealthy persons were under-represented from all groups.

Figure 1
Figure 1

Relative risk of non-participation and mortality rate ratio for non-participants compared with participants by sociodemographic variables. Relative risks adjusted for sex and age 5 years at invitation. Mortality rate ratios adjusted for sex, 5-year age group at follow-up and calendar year. Age groups were not adjusted for age. Economic status available only for persons aged 30–64 years at invitation.

Previous studies

Differences in survey participation across population subgroups have been seen in basically all surveys. In the UK Biobank, participation of men was lower than that of women, and participation was lower from people in their 40s than those in their 60s.17 In the Dutch LifeLines cohort, women constituted a larger proportion of participants than they did in the source population, and so did married/cohabitating persons.18

When the source population is well-known, weighting of responses with the population distribution is an established method to estimate the population representative response pattern.19 The Danish National Health Profile is a questionnaire-based survey of the citizens’ health with the aim of providing data for ‘targeted health promotion, prevention and treatment’.20 In the last survey in 2021, 324 000 persons were invited, and 57% participated. Among men, 37% aged 16–24 years participated compared with 74% aged 65–74 years. To obtain data representative of the Danish population, responses were weighted by sex, age, education, income, socioeconomic group, family type, ethnicity, owner/renter of dwelling, number of visits to general practitioner (GP) and number of hospital admissions in 2019.21 So, when for instance a prevalence of severe sleeping disorders of 15% was reported, this estimate was supposed to reflect the general population.

Less studied, although well established, is the excess mortality in non-participants compared with participants. In the Whitehall II cohort, non-participants compared with participants who were followed up for 10 years had an adjusted HR of all-cause mortality of 2.10 (95% CI 1.72 to 2.57); after 15 years, it was 2.00 (95% CI 1.64 to 2.45) and after 20 years, 1.83 (95% CI 1.56 to 2.16).22 A similar pattern was seen in the Norwegian HUNT Study where non-participants followed for 3 years had an HR of 2.80 (95% CI 2.54 to 3.09); after 14 years, 1.72 (95% CI 1.66 to 1.78); and after 25 years, 1.50 (95% CI 1.44 to 1.57).23 A decreasing excess mortality rate in non-participants by the time of follow-up was also seen in our data.

The excess mortality of non-participants compared with participants may also vary across socioeconomic groups. During 10 years of follow-up of the FINRISK Surveys from 1972 to 1992, the all-cause mortality of non-participating compared with participating men was 1.87 (95% CI 1.22 to 2.86) for upper-level non-manual employees; 2.46 (95% CI 1.69 to 3.59) for low-level non-manual employees; and 3.18 (95% CI 2.52 to 4.01) for manual workers, with a narrower range for women (1.95, 2.54 and 2.64, respectively).24 In a 15-year follow-up of the Danish Diet, Cancer and Health cohort, the excess mortality of non-participants compared with participants was 1.73 (95% CI 1.66 to 1.79) for men and 2.10 (95% CI 2.01 to 2.20) for women. This excess mortality was seen across all educational groups. Using higher-educated participating men as baseline, they had an MRR of 1.77 (95% CI 1.63 to 1.94), while basic/high school educated non-participating men had an MRR of 3.68 (95% CI 3.41 to 3.98).25

The FINRISK and Diet, Cancer and Health data were in accordance with what we found in LOFUS. All non-participants had an excess mortality compared with participants, but the excess was more marked for persons on public support than for self-supported persons.

Strengths and limitations

A strength of the study was the complete follow-up for vital status for all people invited to LOFUS. Furthermore, all estimates were numerically stable with narrow CIs. Invitation of household members meant that single households were slightly under-represented. We used log-binomial analyses instead of the traditional logistic regression as we wanted to know not only the direction of associations but also the size. For example, the non-participation proportion of invited persons was 78% in in-migrants and 62% in long-term residents, giving an RR of 1.26, but with an OR of 2.17 (=(4055×17 336)/(28 067×12 153)).

RRs were adjusted for sex and age 5-year age group at invitation. MRRs were adjusted for sex, age 5-year age group at follow-up, and calendar year, because the full model including all covariates did not converge.

Interpretation

The starting point for the present study was the paradoxical observation of an excess mortality in Lolland-Falster, while LOFUS health data were in line with levels in other parts of Denmark. Although we found only modest differences in participation across subgroups, selective participation may explain part of the paradox. In the weighted data from the Danish National Health Survey, chronic obstructive pulmonary disease was reported by 8% in Lolland-Falster and 5% nationwide; osteoarthritis by 34% vs 23%; obesity by 25% vs 19%; daily smoking by 21% vs 14%; and excess alcohol intake by 15% vs 16%.20 The pattern in the weighted results was overall in line with what we would expect from the population-based mortality data. Nevertheless, weighting is made under the assumption that the characteristics of non-participants in a given subgroup equal that of participants from the same subgroup. However, this may not be true for health characteristics, as non-participants in the years following invitation had a considerably higher mortality than participants. So, for instance, in the Danish National Health Survey, the weighted prevalence of severe sleeping disorders was 15%, but the true prevalence may be higher because weighting is unlikely to account for the in-group health selection even when weighting included visits to GPs and hospitalisation.21

We found the measured prevalence of airway obstructions in LOFUS participants in line with the prevalence in other parts of Denmark.11 In the Danish National Health Survey data, the weighted, self-reported prevalence of chronic obstructive pulmonary disease was 60% (=8.4%/5.2%) higher in Lolland-Falster than nationally.20 So, selection between groups could have played a role. But even more important was probably the selection within groups; the mortality from respiratory diseases was 4.54 higher in non-participants than in participants in LOFUS. One should therefore be cautious about using health survey data for prioritising health interventions.

Health surveys have not only served the purpose of mapping population profiles as a basis for health policy, but also of providing prospective cohort data for identification of risk factors. For this purpose, selective participation of healthy individuals may actually be seen as an advantage. In order to exclude reverse causation deriving from behavioural patterns caused by prevalent disease, it is standard in the analysis of prospective cohort studies to exclude participants with prevalent diseases at the time of recruitment. The philosophy being that the purpose of prospective cohort studies is to identify associations between risk factors and disease occurrence, and that these associations will be valid on the population level even when derived from selected subpopulations.26

Lately, this understanding of the validity of findings from prospective cohort studies has been challenged.27 The UK Biobank had a response rate of 5.45%.16 In order to test for the potential impact of selective responses, a post-stratification was undertaken using the Health Survey of England 2008 (HSE). The HSE had a response rate of 64% and used age, sex, household type, geographical region and social class as non-responder weights. The general population estimates from the HSE were used as input for weighting of the UK Biobank data by age, sex, education, smoking, physical activity and body mass index, where weighted totals from the UK Biobank were summed to the totals of the UK population.

Weighted UK Biobank data had younger, less educated and less physically active persons than those in the unweighted data. Excluding persons with cancer or cardiovascular disease at baseline, 302 009 UK Biobank participants remained, of whom 11 875 died during follow-up. In the unweighted UK Biobank data, a protective effect was seen on death from cardiovascular disease of current as compared with never drinking (HR of 0.60–0.66). These associations disappeared in the weighted data (HR 0.93–1.00), indicating an over-representation of healthy lives among UK Biobank participants reporting current drinking. This finding is an important reminder of the risk of generating spurious associations from incomplete data, but the weighting might in itself have generated problems as one-fourth of the data had been excluded due to missing values. Furthermore, the fact that all other studied associations remained largely unchanged indicated some resilience of associations generated from selected populations.

Conclusion

LOFUS was a population-based health survey undertaken in an area with relatively high mortality. Nevertheless, health profiles from LOFUS resembled those seen in other parts of Denmark. About one-third of persons invited to LOFUS participated. Using register data available for all invited persons, we saw some modest sociodemographic differences in participation in LOFUS, but this was not systematically related to health, as for example, elderly people had higher participation than younger people. However, in a mortality follow-up of all invited persons, non-participants had systematically three times higher mortality than participants. Our study therefore indicated within-group selection to be much more important than between-group selection for the lack of population representativeness of the survey data.